These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Evaluation of Hancock mitral valve by M-mode echocardiography. Clinical significance of the timing of closing and opening of the valve].
    Author: Futamata H, Matsushita S, Shimizu M, Kamio Y, Takizawa Y, Imura T, Matsubara F, Genda A, Tsuchiya K.
    Journal: J Cardiogr; 1983 Mar; 13(1):125-36. PubMed ID: 6644102.
    Abstract:
    The valve function of a Hancock xenograft in the mitral position was evaluated by M-mode echocardiograms guided by the two-dimensional echocardiogram. From M-mode echocardiograms, the intervals from the second heart sound to mitral valve opening (II-MVo) and from the Q wave to mitral valve closure (Q-MVc) were measured in 24 patients with a Hancock xenograft, 16 with mitral stenosis (MS) and 20 normal controls. Twenty-four patients with a Hancock xenograft were divided into four groups according to the echocardiographic pattern of the xenograft. Fourteen with normal echocardiograms (I: N.P.), five with delayed opening of cusps from 20 to 90 msec (II: D.O.), three with a coarse fluttering of cusps in diastole (III: D.F.), and two with an obstructed prosthesis (IV: O.P.). The valve function of groups II and III was clinically normal. This suggests that a coarse fluttering of cusps and delayed opening of cusps do not always indicate malfunction of the Hancock xenograft. M-mode echocardiograms of group IV showed an increased thickening of cusps, multiple dense echoes between valve stents and a lack of a clear E point. The beat-to-beat variations of Q-MVc and II-MVo intervals showed no significant differences among patients with the Hancock xenograft, MS and normal controls. A small time-dependent variation of Q-MVc and II-MVo intervals observed in patients with the Hancock xenograft did not seem to interfere the reliable reproducibility of these intervals. In group I, II-MVo interval was 104 +/- 8 msec (mean +/- S.E.), which was significantly longer than that of normal controls (54.5 +/- 2.5 msec) (p less than 0.005). In groups II and III, II-MVo interval was almost equal to that of group I, but in two of group IV, this interval was 20 and 30 msec, respectively which was markedly shortened. Q-MVc intervals did not show significant differences among groups I, II, III and IV. There were significant differences in Q-MVc interval among patients with MS and the Hancock xenograft and normal controls. II-MVo interval of group I was inversely correlated with mean diastolic posterior wall velocity (MDPWV), stroke index (SI) and delta ejection time (ET), but significantly correlated with delta preejection period (PEP) and PEP/ET. However, there was no significant relationship between II-MVo interval and pulmonary capillary wedge pressure. This suggested that prolonged II-MVo interval reflects postoperative left ventricular dysfunction. In conclusion, to evaluate the function of a Hancock xenograft, echocardiograms of valve cusps and measurement of II-MVo interval have useful clinical significance.
    [Abstract] [Full Text] [Related] [New Search]